The Alcian blue and combined Alcian blue--Safranin O staining of glycosaminoglycans studied in a model system and in mast cells.
Polyacrylamide films containing different glycosaminoglycans have been applied to the study of the Alcian Blue and combined Alcian Blue--Safranin O staining procedures. It was found that the polyacrylamide matrix can be interpreted as some kind of 'barrier' around the substrate molecules, a situation which can be compared to a certain extent with what occurs in situ, where complex protein molecules can likewise form a 'barrier'. The Alcian Blue staining of the model films was found to follow the Lambert-Beer law. The time to reach optimal dye binding depended on the concentration of the glycosaminoglycan enclosed in the model films and on the concentration of Alcian Blue in the dye solution. Lowering the pH of the dye solution appeared to increase the rate of staining. Optimal staining of model films in the presence of salt or urea was not possible, because under these conditions the pores of the polyacrylamide matrix became blocked. Alcian Blue was found to bind irreversibly to the glycosaminoglycan molecules enclosed in the polyacrylamide films. The results of the combined Alcian Blue-Safranin O staining applied to model films appeared to be highly dependent on the amount of Alcian Blue bound to the glycosaminoglycan in the first step of the double staining procedure. No specific differences were noticed between the behaviour of the different glycosaminoglycan-Alcian Blue complexes towards the Safranin O binding in the next step. As the theoretical basis for the application of the combined Alcian Blue-Safranin O staining was also found not to be completely valid, the conclusion was reached that this double staining cannot be used for the histochemical identification of glycosaminoglycans. The colour retained by a certain glycosaminoglycan-containing part of the specimen only delivers information about the accesibility of that part for Alcian Blue.
D000423:Alcian Blue; D000818:Animals; D002809:Chondroitin Sulfates / Q000032:analysis; D006224:Cricetinae; D003594:Cytoplasmic Granules / Q000032:analysis; D006025:Glycosaminoglycans / Q000032:analysis*; D006493:Heparin / Q000032:analysis; D006497:Heparan Sulfate / Q000032:analysis; D006820:Hyaluronic Acid / Q000032:analysis; D006863:Hydrogen-Ion Concentration; D007211:Indoles; D007632:Keratan Sulfate / Q000032:analysis; D008407:Mast Cells / Q000032:analysis; D051381:Rats; D013194:Staining and Labeling
D000423:Alcian Blue; D002809:Chondroitin Sulfates; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; D006820:Hyaluronic Acid; D007211:Indoles; D007632:Keratan Sulfate